Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 2 hours 6 min ago

Drilling Tools International misses top-line and bottom-line estimates; reaffirms FY26 outlook

Fri, 05/08/2026 - 00:09

Patria Investments Limited 2026 Q1 - Results - Earnings Call Presentation

Fri, 05/08/2026 - 00:05

Trump reportedly plans smaller CEO delegation for Beijing summit

Fri, 05/08/2026 - 00:05

Gran Tierra GAAP EPS of -$3.38 misses by $2.06, revenue of $172.06M beats by $19.06M

Fri, 05/08/2026 - 00:04

Gilead targets $1B Yeztugo sales in 2026 while raising base business outlook to $29.4B-$29.8B

Fri, 05/08/2026 - 00:02

HubSpot: Risks Mounting, But Valuation Is Too Cheap To Ignore

Fri, 05/08/2026 - 00:02

Sprout Social, Inc. 2026 Q1 - Results - Earnings Call Presentation

Fri, 05/08/2026 - 00:02

Ormat Technologies, Inc. 2026 Q1 - Results - Earnings Call Presentation

Fri, 05/08/2026 - 00:01

Which Railroad Belongs In Your Dividend Portfolio?

Fri, 05/08/2026 - 00:00

Goldman Sachs BDC Non-GAAP NII of $0.22 misses by $0.08, TII of $78.8M misses by $4.98M

Thu, 05/07/2026 - 23:58

GoodRx raises 2026 outlook to $765M-$785M revenue and at least $235M adjusted EBITDA, led by Pharma Direct

Thu, 05/07/2026 - 23:54

Open Lending targets 100,000 to 110,000 certified loans in 2026 while projecting $25M to $29M adjusted EBITDA

Thu, 05/07/2026 - 23:52

Amneal Pharmaceuticals beats top-line and bottom-line estimates; reaffirms FY26 outlook

Thu, 05/07/2026 - 23:51

Teradyne: Market Command And Heavy Demand

Thu, 05/07/2026 - 23:51

Western Asset GSM 5-Year Portfolios Q1 2026 Commentary

Thu, 05/07/2026 - 23:45

LightPath outlines $6M CapEx plan while targeting gross margin move toward 40% amid capacity expansion

Thu, 05/07/2026 - 23:42

Scorpio Tankers prices $150M reopening of 1.75% convertible notes due 2031, launches share repurchase

Thu, 05/07/2026 - 23:40

Commerce.com: Not Out Of The Woods Yet With Weak Growth, High Churn

Thu, 05/07/2026 - 23:39

Palvella targets 2H 2026 NDA filing while outlining >$1B peak U.S. sales potential for QTORIN rapamycin in microcystic lymphatic malformations

Thu, 05/07/2026 - 23:32

Arcturus outlines 12-week ARCT-032 Phase II enrollment and extends cash runway beyond Q2 2028

Thu, 05/07/2026 - 23:32

Pages